Výsledky vyhledávání - "Maya, Srivastava"

Abstract 3065: Increased longevity and quality of life with treatment with a progesterone receptor modulator in a patient with treatment resistant stage IV small cell lung cancer

Autor: Jerome H. Check, Carrie Wilson, Diane Check, Trina Poretta, Maya Srivastava

Publikováno v: Cancer Research. 83:3065-3065

The progesterone receptor modulator, mifepristone, has been found to provide extension of life by years and marked palliative benefits in several cases of non-small cell lung cancer (NSCLC) despite progression with platinum-based chemotherapy, check-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::02aca3c50844fc24205cac09e77b30f5
https://doi.org/10.1158/1538-7445.am2023-3065

Zobrazit plný text záznamu

Abstract 695: Treatment with oral mifepristone enables a patient with end-stage pancreatic cancer in hospice, on a morphine drip, to restore a decent quality of life

Autor: Maya Srivastava, Diane Check, Carrie Wilson, James Aikins, Trina Poretta, Jerome H. Check

Publikováno v: Cancer Research. 80:695-695

The progesterone (P) receptor modulator, mifepristone, has been previously found to provide significant improvement in length and quality of life in people with a variety of advanced cancers. A 57 year old man with severe abdominal pain, dyspnea, nau

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0ffd003a3e92e5c885aaa6a4aca67e9e
https://doi.org/10.1158/1538-7445.am2020-695

Zobrazit plný text záznamu

Abstract 586: Sera levels of the immunomodulatory protein the progesterone induced blocking factor (PIBF) are not useful in determining which patients with non-small cell lung cancer will respond to progesterone receptor modulators, e.g., mifepristone

Autor: Ann DiAntonio, Maya Srivastava, Diane Check, Jerome H. Check

Publikováno v: Cancer Research. 78:586-586

Human leukemia cancer cell line studies have demonstrated the presence of a 34 kDa intracytoplasmic splice variant of the parent 90 kDa nuclear protein associated with the centrosome that has significant immunosuppressive activity, especially, but no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6bd74983821e48dada678086f700ae59
https://doi.org/10.1158/1538-7445.am2018-586

Zobrazit plný text záznamu

Attempts to induce differentiation of neoplastic cells to normal

Autor: Julian L, Ambrus, Clara M, Ambrus, Selina, Akhtar, Maya, Srivastava

Publikováno v: Discovery medicine. 5(28)

Extract: It was a long time dream of oncologists to find agents which would cause differentiation to normal of neoplastic cells, thus "taming cancer" without harming normal cells. Our group was involved in such attempts for several decades. Here we s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2077421314497d928ea53958baf64b24
https://pubmed.ncbi.nlm.nih.gov/20704881

Zobrazit plný text záznamu

Abstract 1282: Comparison of serum progesterone levels of the immunomodulatory protein, the progesterone induced blocking factor, in people with BRCA-2 mutations associated with and not associated with a high risk of cancer

Autor: Duroseau M, Jerome H. Check, Michael Dougherty, Jamie Vaniver, Gabrielle DiAntonio, Maya Srivastava

Publikováno v: Cancer Research. 75:1282-1282

The BRCA genes normally provide proteins important in degradating the progesterone (P) receptor. BRCA1 and 2 mutations may make mutated protein, leading to prolongation of P receptor activity which may be involved in the mechanism of how these mutati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e83940f3ea6c8e35986ce2506e4eb62c
https://doi.org/10.1158/1538-7445.am2015-1282

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání